In this study, proCAFs act as the initial infection-responsive population carrying ZFP36 and THBS1 programs, while iCAFs represent a later expansion phase that spatially interacts with tumor cells and consolidates stromal-immune suppression. The gene discussed is ZFP36; the disease is neoplasm.